Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 24729-96-2
2. St075182
3. Dtxsid80860321
4. Methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-2-o-phosphono-1-thiooctopyranoside
5. Akos015960484
6. Ncgc00389304-01
7. Ac-11380
8. Methyl7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside2-(dihydrogenphosphate)
9. Db-046536
10. Ft-0603210
| Molecular Weight | 505.0 g/mol |
|---|---|
| Molecular Formula | C18H34ClN2O8PS |
| XLogP3 | -1.2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 504.1462019 g/mol |
| Monoisotopic Mass | 504.1462019 g/mol |
| Topological Polar Surface Area | 174 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 658 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 9 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 21 | |
|---|---|
| Drug Name | CLEOCIN |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | PHARMACIA AND UPJOHN (Application Number: N050537); PHARMACIA AND UPJOHN (Application Number: N050680); PHARMACIA AND UPJOHN (Application Number: N050767. Patent: 6495157) |
| 2 of 21 | |
|---|---|
| Drug Name | CLINDA-DERM |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | PADDOCK LLC (Application Number: A063329) |
| 3 of 21 | |
|---|---|
| Drug Name | CLINDAGEL |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | PRECISION DERMAT (Application Number: N050782. Patent: 6387383) |
| 4 of 21 | |
|---|---|
| Drug Name | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | BAXTER HLTHCARE CORP (Application Number: N208083) |
| 5 of 21 | |
|---|---|
| Drug Name | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE |
| Active Ingredient | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Company | ACTAVIS LABS UT INC (Application Number: A205128); MYLAN PHARMS INC (Application Number: A065443); PERRIGO ISRAEL (Application Number: A090979); PERRIGO ISRAEL (Application Number: A202440); TARO (Application Number: A206218); TOLMAR (Application Number: A203688); TOLMAR (Application Number: A204087) |
| 6 of 21 | |
|---|---|
| Drug Name | BENZACLIN |
| Active Ingredient | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Company | VALEANT BERMUDA (Application Number: N050756) |
| 7 of 21 | |
|---|---|
| Drug Name | ACANYA |
| Active Ingredient | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Company | DOW PHARM (Application Number: N050819. Patents: 8288434, 8663699, 8895070, 9078870, 9504704, 9561208) |
| 8 of 21 | |
|---|---|
| Drug Name | CLEOCIN PHOSPHATE |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | PHARMACIA AND UPJOHN (Application Number: A062803); PHARMACIA AND UPJOHN (Application Number: N050441) |
| 9 of 21 | |
|---|---|
| Drug Name | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | ABRAXIS PHARM (Application Number: N050635) |
| 10 of 21 | |
|---|---|
| Drug Name | CLINDESSE |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | PERRIGO PHARMA INTL (Application Number: N050793. Patents: 6899890, 9789057) |
| 11 of 21 | |
|---|---|
| Drug Name | ONEXTON |
| Active Ingredient | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Company | DOW PHARM (Application Number: N050819. Patents: 8288434, 8663699, 8895070, 9078870, 9504704, 9561208) |
| 12 of 21 | |
|---|---|
| Drug Name | CLINDAMYCIN PHOSPHATE AND TRETINOIN |
| Active Ingredient | CLINDAMYCIN PHOSPHATE; TRETINOIN |
| Company | ACTAVIS MID ATLANTIC (Application Number: A202564) |
| 13 of 21 | |
|---|---|
| Drug Name | ZIANA |
| Active Ingredient | CLINDAMYCIN PHOSPHATE; TRETINOIN |
| Company | MEDICIS (Application Number: N050802. Patent: 6387383) |
| 14 of 21 | |
|---|---|
| Drug Name | EVOCLIN |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | MYLAN PHARMS INC (Application Number: N050801. Patents: 7141237, 7374747) |
| 15 of 21 | |
|---|---|
| Drug Name | CLINDETS |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | PERRIGO CO (Application Number: A064136) |
| 16 of 21 | |
|---|---|
| Drug Name | DUAC |
| Active Ingredient | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Company | STIEFEL (Application Number: N050741) |
| 17 of 21 | |
|---|---|
| Drug Name | VELTIN |
| Active Ingredient | CLINDAMYCIN PHOSPHATE; TRETINOIN |
| Company | AQUA PHARMS LLC (Application Number: N050803) |
| 18 of 21 | |
|---|---|
| Drug Name | CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | PHARMACIA AND UPJOHN (Application Number: N050639) |
| 19 of 21 | |
|---|---|
| Drug Name | CLEOCIN T |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | PHARMACIA AND UPJOHN (Application Number: N050537); PHARMACIA AND UPJOHN (Application Number: N050600); PHARMACIA AND UPJOHN (Application Number: N050615) |
| 20 of 21 | |
|---|---|
| Drug Name | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | AKORN INC (Application Number: A203048); BAXTER HLTHCARE CORP (Application Number: A208084); SANDOZ INC (Application Number: A201692) |
| 21 of 21 | |
|---|---|
| Drug Name | CLINDAMYCIN PHOSPHATE |
| Active Ingredient | CLINDAMYCIN PHOSPHATE |
| Company | AKORN (Application Number: A065513); ALVOGEN INC (Application Number: A062800); ALVOGEN INC (Application Number: A062801); ALVOGEN INC (Application Number: A062943); FOUGERA PHARMS INC (Application Number: A064159); FOUGERA PHARMS (Application Number: A064160); FOUGERA PHARMS (Application Number: A065067); FOUGERA PHARMS (Application Number: A065139); FOUGERA PHARMS (Application Number: A065254); FRESENIUS KABI USA (Application Number: A065346); FRESENIUS KABI USA (Application Number: A065347); G AND W LABS INC (Application Number: A062811); GLASSHOUSE PHARMS (Application Number: A209846); MYLAN LABS LTD (Application Number: A204748); MYLAN LABS LTD (Application Number: A204749); PERRIGO NEW YORK (Application Number: A064050); PERRIGO NEW YORK (Application Number: A065049); PERRIGO UK FINCO (Application Number: A090785); SAGENT PHARMS (Application Number: A090108); SAGENT PHARMS (Application Number: A090109); TARO PHARM INDS (Application Number: A065184); TELIGENT PHARMA INC (Application Number: A206945); VINTAGE PHARMS (Application Number: A203343); WEST-WARD PHARMS INT (Application Number: A062889); WEST-WARD PHARMS INT (Application Number: A065206); WOCKHARDT (Application Number: A063304) |
ABOUT THIS PAGE
26
PharmaCompass offers a list of St075182 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right St075182 manufacturer or St075182 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred St075182 manufacturer or St075182 supplier.
PharmaCompass also assists you with knowing the St075182 API Price utilized in the formulation of products. St075182 API Price is not always fixed or binding as the St075182 Price is obtained through a variety of data sources. The St075182 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A St075182 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of St075182, including repackagers and relabelers. The FDA regulates St075182 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. St075182 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A St075182 supplier is an individual or a company that provides St075182 active pharmaceutical ingredient (API) or St075182 finished formulations upon request. The St075182 suppliers may include St075182 API manufacturers, exporters, distributors and traders.
St075182 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of St075182 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right St075182 GMP manufacturer or St075182 GMP API supplier for your needs.
A St075182 CoA (Certificate of Analysis) is a formal document that attests to St075182's compliance with St075182 specifications and serves as a tool for batch-level quality control.
St075182 CoA mostly includes findings from lab analyses of a specific batch. For each St075182 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
St075182 may be tested according to a variety of international standards, such as European Pharmacopoeia (St075182 EP), St075182 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (St075182 USP).
